Champions Oncology Inc
NASDAQ:CSBR
| Market Cap (Intraday) | 66.61M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 490 |
| 10-Day MA | $4.92 |
| 50-Day MA | $4.86 |
| 200-Day MA | $5.36 |
Champions Oncology Inc Stock, NASDAQ:CSBR
One University Plaza, Suite 307, Hackensack, New Jersey 07601
United States of America
Phone: +1.201.808.8400
Number of Employees: 210
Description
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.